McKenzie RS - Search Results

1

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.

Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Duh MS, et al. Among authors: mckenzie rs. Drugs Aging. 2006;23(12):969-76. doi: 10.2165/00002512-200623120-00004. Drugs Aging. 2006. PMID: 17154661

2

Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia.

Papatheofanis FJ, McKenzie RS, Mody SH, Suruki RY, Piech CT. Papatheofanis FJ, et al. Among authors: mckenzie rs. Curr Med Res Opin. 2006 May;22(5):837-42. doi: 10.1185/030079906X100113. Curr Med Res Opin. 2006. PMID: 16709305

3

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.

Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Lefebvre P, et al. Among authors: mckenzie rs. Curr Med Res Opin. 2006 Sep;22(9):1623-31. doi: 10.1185/030079906X120968. Curr Med Res Opin. 2006. PMID: 16968565

4

Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies.

Gosselin A, Pashos CL, Harley C, Mark TL, McKenzie RS. Gosselin A, et al. Among authors: mckenzie rs. Clin Ther. 2006 Oct;28(10):1701-8. doi: 10.1016/j.clinthera.2006.10.009. Clin Ther. 2006. PMID: 17157126

5

Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in anemic predialysis chronic kidney disease patients from an observational study.

Papatheofanis F, Smith C, Mody S, McKenzie RS, Bookhart B, Piech CT. Papatheofanis F, et al. Among authors: mckenzie rs. Am J Ther. 2007 Jul-Aug;14(4):322-7. doi: 10.1097/MJT.0b013e31804bddec. Am J Ther. 2007. PMID: 17667204

6

Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.

Vekeman F, McKenzie RS, Lefebvre P, Watson SH, Mody SH, Piech CT, Duh MS. Vekeman F, et al. Among authors: mckenzie rs. Am J Health Syst Pharm. 2007 Sep 15;64(18):1943-9. doi: 10.2146/ajhp060585. Am J Health Syst Pharm. 2007. PMID: 17823106

7

Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.

Vekeman F, Yameogo ND, Lefebvre P, Bailey RA, McKenzie RS, Piech CT. Vekeman F, et al. Among authors: mckenzie rs. J Med Econ. 2010;13(4):673-80. doi: 10.3111/13696998.2010.529032. Epub 2010 Nov 4. J Med Econ. 2010. PMID: 21050062 Free article.

8

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia.

Ben-Hamadi R, Duh MS, Aggarwal J, Henckler A, McKenzie RS, Tak Piech C. Ben-Hamadi R, et al. Among authors: mckenzie rs. Curr Med Res Opin. 2005 Oct;21(10):1677-82. doi: 10.1185/030079905X65501. Curr Med Res Opin. 2005. PMID: 16238908

9

Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.

Mark TL, McKenzie RS, Fastenau J, Piech CT. Mark TL, et al. Among authors: mckenzie rs. Curr Med Res Opin. 2005 Sep;21(9):1347-54. doi: 10.1185/030079905X56556. Curr Med Res Opin. 2005. PMID: 16197652

10

Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) : a registry for characterizing anaemia management and outcomes in oncology patients.

Larholt K, Pashos CL, Wang Q, Bookhart B, McKenzie RS, Piech CT. Larholt K, et al. Among authors: mckenzie rs. Clin Drug Investig. 2008;28(3):159-67. doi: 10.2165/00044011-200828030-00003. Clin Drug Investig. 2008. PMID: 18266401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters